|
Transplants in Myelodysplastic Syndromes
|
Dec 2014
|
Hematol Oncol Clin North Am.
|
myelodysplastic syndromes (MDS)
|
|
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
|
Jul 2023
|
Transplantation and Cellular Therapy
|
myelodysplastic syndromes (MDS)
|
|
Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens
|
Dec 2016
|
Hematology Am Soc Hematol Educ Program
|
myelodysplastic syndromes (MDS)
|
|
Transplantation for myelodysplastic syndromes 2013.
|
Nov 2013
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
|
Apr 2023
|
Transplantation and Cellular Therapy
|
myelodysplastic syndromes (MDS)
|
|
Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia
|
Jun 2014
|
Leuk Res Rep
|
aplastic anemia
|
|
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care
|
Jun 2018
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
|
Apr 2016
|
Anemia
|
myelodysplastic syndromes (MDS)
|
|
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes
|
Apr 2021
|
Hematology/oncology clinics of North America
|
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
|
|
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
|
Jul 2020
|
Blood
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
